Canadian regulators say pharma overcharged

The regulators want you to know they're watching: Canadian pharmaceutical companies overcharged for patented drugs by about $27 million last year, according to the watchdog agency that regulates prices. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.